ZEHENTMAYR FRANZ
Universitätsklinik für Radiotherapie und Radio-Onkologie
Universitätsinstitut für Technologieentwicklung in der Strahlentherapie
Publikationen
|
Forscherprofil
65 Publikationen
2022
Beiträge in Fachzeitschriften
[Impact of physical activity before, during, and after chemotherapy on cognitive functions in patients with breast cancer: results of a prospective US study].
Fastner, G; Zehentmayr, F
STRAHLENTHER ONKOL. 2022; 198(7): 670-673.
Editorials
High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC.
Grambozov, B; Stana, M; Kaiser, B; Karner, J; Gerum, S; Ruznic, E; Zellinger, B; Moosbrugger, R; Studnicka, M; Fastner, G; Sedlmayer, F; Zehentmayr, F;
Cancers (Basel). 2022; 14(3):
Übersichtsarbeiten
Carbon Monoxide Diffusing Capacity (DL
Stana, M; Grambozov, B; Gaisberger, C; Karner, J; Ruznic, E; Berchtold, J; Zellinger, B; Moosbrugger, R; Studnicka, M; Fastner, G; Sedlmayer, F; Zehentmayr, F;
Diagnostics (Basel). 2022; 12(5):
Originalarbeiten (Zeitschrift)
Durvalumab after Sequential High Dose Chemoradiotherapy versus Standard of Care (SoC) for Stage III NSCLC: A Bi-Centric Trospective Comparison Focusing on Pulmonary Toxicity.
Wass, R; Hochmair, M; Kaiser, B; Grambozov, B; Feurstein, P; Weiss, G; Moosbrugger, R; Sedlmayer, F; Lamprecht, B; Studnicka, M; Zehentmayr, F
CANCERS. 2022; 14(13):
Originalarbeiten (Zeitschrift)
Hsa-miR-3651 could serve as a novel predictor for in-breast recurrence via FRMD3.
Zellinger, B; Bodenhofer, U; Engländer, IA; Kronberger, C; Grambozov, B; Ruznic, E; Stana, M; Karner, J; Fastner, G; Sotlar, K; Sedlmayer, F; Zehentmayr, F;
Breast Cancer. 2022; 29(2): 274-286.
Originalarbeiten (Zeitschrift)
2021
Beiträge in Fachzeitschriften
Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
Grambozov, B; Nussdorfer, E; Kaiser, J; Gerum, S; Fastner, G; Stana, M; Gaisberger, C; Wass, R; Studnicka, M; Sedlmayer, F; Zehentmayr, F;
Curr Oncol. 2021; 28(3):1835-1846
Originalarbeiten (Zeitschrift)
Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single-center retrospective analysis.
Grambozov, B; Wass, R; Stana, M; Gerum, S; Karner, J; Fastner, G; Studnicka, M; Sedlmayer, F; Zehentmayr, F
THORAC CANCER. 2021; 12(8): 1162-1170.
Originalarbeiten (Zeitschrift)
In-field stereotactic body radiotherapy (SBRT) reirradiation for pulmonary malignancies as a multicentre analysis of the German Society of Radiation Oncology (DEGRO)
John, C; Dal Bello, R; Andratschke, N; Guckenberger, M; Boda-Heggemann, J; Gkika, E; Mantel, F; Specht, HM; Stromberger, C; Zehentmayr, F; Blanck, O; Balermpas, P
SCI REP-UK. 2021; 11(1): 4590
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Second stereotactic Radiotherapy as Re-Irradiation for Patients with thoracic Malignancies: A multicenter DEGRO-Analysis
John, C; Dal Bello, R; Andratschke, N; Guckenberger, M; Boda-Heggemann, J; Gkika, E; Mantel, F; Specht, H; Stromberger, C; Zehentmayr, F; Blanck, O; Balermpas, P
STRAHLENTHER ONKOL. 2021; 197(SUPPL 1): S68-S69.
Abstracts (Zeitschrift)
Second In-field course of stereotactic body radiotherapy for thoracic tumors: a multicentre analysis
John, C; Dal Bello, R; Andratschke, N; Guckenberger, M; Boda-Heggemann, J; Gkika, E; Mantel, F; Specht, HM; Stromberger, C; Zehentmayr, F; Blanck, O; Balermpas, P
RADIOTHER ONCOL. 2021; 161: S708-S709.
Abstracts (Zeitschrift)
2020
Beiträge in Fachzeitschriften
Toxicity and cosmetic outcome after hypofractionated whole breast irradiation and boost-IOERT in early stage breast cancer (HIOB): First results of a prospective multicenter trial (NCT01343459).
Fastner, G; Reitsamer, R; Urbański, B; Kopp, P; Murawa, D; Adamczyk, B; Karzcewska, A; Milecki, P; Hager, E; Reiland, J; Ciabattoni, A; Matuschek, C; Budach, W; Nowell, K; Schumacher, C; Ricke, A; Fusco, V; Vidali, C; Alessandro, M; Ivaldi, GB; Ziegler, I; Fussl, C; Zehentmayr, F; Grambozov, B; Sir, A; Hitzl, W; Ricardi, U; Sedlmayer, F;
Radiother Oncol. 2020; 146: 136-142.
Originalarbeiten (Zeitschrift)
Vertebral metastases of functional vaginal paraganglioma treated with radiation therapy: A case report
Grambozov, B; Sedlmayer, F; Lottspeich, C; Reincke, M; Zehentmayr, F;
Current Problems in Cancer: Case Reports. 2020;
Fallberichte
Pulmonary function decreases moderately after accelerated high-dose irradiation for stage III non-small cell lung cancer.
Grambozov, B; Wolf, F; Kaiser, J; Wass, R; Fastner, G; Gaisberger, C; Rettenbacher, L; Studnicka, M; Pirich, C; Sedlmayer, F; Zehentmayr, F;
Thorac Cancer. 2020; 11(2):369-378
Originalarbeiten (Zeitschrift)
Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review.
Zehentmayr, F; Grambozov, B; Kaiser, J; Fastner, G; Sedlmayer, F;
Thorac Cancer. 2020; 11(6): 137-1385.
Übersichtsarbeiten
Hsa-miR-375/RASD1 Signaling May Predict Local Control in Early Breast Cancer.
Zellinger, B; Bodenhofer, U; Engländer, IA; Kronberger, C; Strasser, P; Grambozov, B; Fastner, G; Stana, M; Reitsamer, R; Sotlar, K; Sedlmayer, F; Zehentmayr, F;
Genes (Basel). 2020; 11(12):
Originalarbeiten (Zeitschrift)
2019
Beiträge in Fachzeitschriften
NSCLC stages IIa-IIIc: Tumor related IGRT yields better local control than kV-guidance to anatomic structures.
Zehentmayr, F; Karner, J; Wurstbauer, K; Wass, RE; Fastner, G; Rettenbacher, L; Studnicka, M; Pirich, C; Sedlmayer, F; Kopp, P;
Ann Oncol. 2019; 30 Suppl 2:ii63
Originalarbeiten (Zeitschrift)
Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation.
Zehentmayr, F; Sprenger, M; Rettenbacher, L; Wass, R; Porsch, P; Fastner, G; Pirich, C; Studnicka, M; Sedlmayer, F;
Thorac Cancer. 2019; 10(2):321-329
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Hypofractionated whole breast irradiation and IOERT in breast cancer: Toxicity and cosmetic outcome
Fastner, G; Reitsamer, R; Peter, K; Ingrid, Z; Fussl, C; Zehentmayr, F; Grambozov, B; Hitzl, W; Murawa, D; Karzcewska, A; Milecki, P; Urbanski, B; Hager, E; Reiland, J; Ciabattoni, A; Matuschek, C; Budach, W; Brimmer, R; Schumacher, C; Ricke, A; Ricardi, U; Fusco, V; Sedlmayer, F
RADIOTHER ONCOL. 2019; 133: S700-S700.
Abstracts (Zeitschrift)
NSCLC stages IIa-IIIc: Tumor related IGRT yields better local control than kV-guidance to anatomic structures
Zehentmayr, F; Karner, J; Wurstbauer, K; Wass, RE; Fastner, G; Rettenbacher, L; Studnicka, M; Pirich, C; Sedlmayer, F; Kopp, P
ANN ONCOL. 2019; 30:
Abstracts (Zeitschrift)
2018
Beiträge in Fachzeitschriften
Nonmetastatic pancreatic cancer : Improved survival with chemoradiotherapy > 40 Gy after systemic treatment.
Bachmayer, S; Fastner, G; Vaszi, A; Iglseder, W; Kopp, P; Holzinger, J; Dinnewitzer, A; Rinnerthaler, G; Gampenrieder, SP; Emmanuel, K; Greil, R; Sedlmayer, F; Zehentmayr, F;
Strahlenther Onkol. 2018; 194(7): 627-637.
Originalarbeiten (Zeitschrift)
Intraoperative Tumor Bed Boost With Electrons in Breast Cancer of Clinical Stages I Through III: Updated 10-Year Results.
Kaiser, J; Kronberger, C; Moder, A; Kopp, P; Wallner, M; Reitsamer, R; Fischer, T; Fussl, C; Zehentmayr, F; Sedlmayer, F; Fastner, G;
Int J Radiat Oncol Biol Phys. 2018; 102(1): 92-101.
Originalarbeiten (Zeitschrift)
Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer
Kaiser, J; Reitsamer, R; Kopp, P; Gaisberger, C; Kopp, M; Fischer, T; Zehentmayr, F; Sedlmayer, F; Fastner, G
BREAST CARE. 2018; 13(3): 162-167.
Übersichtsarbeiten
Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer : Impact on long-term outcome. Results of the phase II TAKO 05/ABCSG R‑02 trial.
Kogler, P; DeVries, AF; Eisterer, W; Thaler, J; Sölkner, L; Öfner, D;
Strahlenther Onkol. 2018; 194(1): 41-49.
Originalarbeiten (Zeitschrift)
– Beitrag als Studygroup-Member
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Pulmonary function remains constant after DART in patients with NSCLC stage III
Zehentmayr, F; Wolf, F; Kaiser, J; Windischbauer, S; Kopp, P; Fastner, G; Wass, R; Porsch, P; Studnicka, M; Sedlmayer, F;
Pulmonary function remains constant after DART in patients with NSCLC stage III. 2018; -ÖGRO Jahrestagung 2018; 28.-29.09.2018; Salzburg.
Abstracts (Zeitschrift)
Overtreatment in early lung cancer: Survival is independent of pathological confirmation
Zehentmayr, F; Sprenger, M; Fastner, G; Sedlmayer, F
J THORAC ONCOL. 2018; 13(4): S55-S56.
Abstracts (Zeitschrift)
Survival in early lung cancer patients treated with DART or SBRT depends on co-morbidity
Zehentmayr, F; Sprenger, M; Rettenbacher, L; Wass, R; Porsch, P; Fastner, G; Pirich, C; Studnicka, M; Sedlmayer, F;
Survival in early lung cancer patients treated with DART or SBRT depends on co-morbidity. 2018; -ÖGRO Jahrestagung 2018; 28.-29.09.2018; Salzburg.
Abstracts (Zeitschrift)
2017
Beiträge in Fachzeitschriften
Intraoperative radiotherapy (IORT) as boost in breast cancer.
Sedlmayer, F; Reitsamer, R; Wenz, F; Sperk, E; Fussl, C; Kaiser, J; Ziegler, I; Zehentmayr, F; Deutschmann, H; Kopp, P; Fastner, G;
Radiat Oncol. 2017; 12(1): 23
Übersichtsarbeiten
DART-bid for loco-regionally advanced NSCLC
Wurstbauer, K; Zehentmayr, F; Deutschmann, H; Dagn, K; Exeli, AK; Kopp, P; Porsch, P; Maurer, B; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2017; 193(4): 315-323.
Originalarbeiten (Zeitschrift)
2016
Beiträge in Fachzeitschriften
Survival and local control rates of triple-negative breast cancer patients treated with boost-IOERT during breast-conserving surgery.
Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Fussl, C; Fischer, T; Deutschmann, H; Sedlmayer, F;
Strahlenther Onkol. 2016; 192(1): 1-7.
Originalarbeiten (Zeitschrift)
A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.
Niyazi, M; Pitea, A; Mittelbronn, M; Steinbach, J; Sticht, C; Zehentmayr, F; Piehlmaier, D; Zitzelsberger, H; Ganswindt, U; Rodel, C; Lauber, K; Belka, C; Unger, K
Oncotarget. 2016; 7(29):45764-45775
Originalarbeiten (Zeitschrift)
miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.
Rinnerthaler, G; Hackl, H; Gampenrieder, SP; Hamacher, F; Hufnagl, C; Hauser-Kronberger, C; Zehentmayr, F; Fastner, G; Sedlmayer, F; Mlineritsch, B; Greil, R;
Int J Mol Sci. 2016; 17(2):
Originalarbeiten (Zeitschrift)
Hsa-miR-375 is a predictor of local control in early stage breast cancer.
Zehentmayr, F; Hauser-Kronberger, C; Zellinger, B; Hlubek, F; Schuster, C; Bodenhofer, U; Fastner, G; Deutschmann, H; Steininger, P; Reitsamer, R; Fischer, T; Sedlmayer, F;
Clin Epigenetics. 2016; 8: 28
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Konventionelle Ganzbrustbestrahlung mit intraoperativem Elektronen-Boost des brusterhaltend operierten Mammakarzinoms im Stadium I-III: Aktualisierte 10 –Jahres Resultate
Fastner, G; Kaiser, J; Kopp, P; Wallner, M; Reitsamer, R; Fischer, T; Fussl, C; Zehentmayr, F; Sedlmayer, F
Strahlentherapie und Onkologie. 2016; 192 Suppl 1: 17-17.-22. Jahrestagung der Deutschen Gesellschaft für Radioonkologie; 16.-19.06.2016; Mannheim.
Abstracts (Zeitschrift)
Hypofraktionierte Ganzbrustbestrahlung mit intraoperativem Elektronen-Boost beim brusterhaltend operierten Mammakarzinom (HIOB): Aktualisierte Resultate einer prospektiv multizentrischen Studie
Fastner, G; Reitsamer, R; Fussl, C; Kopp, P; Zehentmayr, F; Milecki, P; Karzcewska, A; Murawa, D; Hager, E; Ciabattoni; Budach, W; Matuschek, C; Brimmer, R; Reiland, J; Schumacher, C; Ricke, A; Ricardi, U; Fusco, V; Vidali, C; Ivaldi, GB; Alessandro, M; Fischer, T; Sedlmayer, F
Strahlentherapie und Onkologie. 2016; 192 (Suppl 1): 32-32.-22. Jahrestagung der Deutschen Gesellschaft für Radioonkologie ; 16.-19.06.2016; Mannheim.
Abstracts (Zeitschrift)
Hsa-miR-375 and local control in early stage breast cancer
Zellinger, B; Zehentmayr, F; Hauser-Kronberger, C; Strasser, P; Bodenhofer, U; Fastner, G; Reitsamer, R, Fischer, T; Sedlmayer, F;
Abstract Book 24th Biennial Congress of the European Association for Cancer Research. 2016; -EACR24; 09.-12.07.2016; Manchester.
Abstracts (Zeitschrift)
2015
Beiträge in Fachzeitschriften
IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F;
Int J Cancer. 2015; 136(5):1193-1201
Originalarbeiten (Zeitschrift)
Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).
Zehentmayr, F; Söhn, M; Exeli, AK; Wurstbauer, K; Tröller, A; Deutschmann, H; Fastner, G; Fussl, C; Steininger, P; Kranzinger, M; Belka, C; Studnicka, M; Sedlmayer, F;
Radiat Oncol. 2015; 10(1): 121
Originalarbeiten (Zeitschrift)
DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily : High local control in early stage (I/II) non-small-cell lung cancer.
Zehentmayr, F; Wurstbauer, K; Deutschmann, H; Fussl, C; Kopp, P; Dagn, K; Fastner, G; Porsch, P; Studnicka, M; Sedlmayer, F;
Strahlenther Onkol. 2015; 191(3): 256-263.
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Triple negative breast cancer patients treated by boost-IOERT during breast conserving surgery
Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Fussl, C; Fischer, T; Dietze, O; Sedlmayer, F
BREAST. 2015; 24: S131-S131.
Abstracts (Zeitschrift)
Clinical results of triple negative breast cancer patients treated by IOERT-boost during breast conserving surgery
Fastner, G; Hauser-Kronberger, C; Moder, A; Reitsamer, R; Zehentmayr, F; Kopp, P; Greil, R; Fischer, T; Dietze, O; Sedlmayer, F;
Radiotherapy and Oncology. 2015; 115(Supplement 1):235-235.-ESTRO 2015; 24.-28.04.2015; Barcelona.
Abstracts (Zeitschrift)
NTCP-Models for Esophagitis with Dose-Differentiated-Radiotherapy (DART-Bid)
Zehentmayr, F; Sohn, M; Exeli, AK; Wurstbauer, K; Troller, A; Deutschmann, H; Fastner, G; Fussl, C; Steininger, P; Kranzinger, M; Belka, C; Studnicak, M; Sedlmayer, F
J THORAC ONCOL. 2015; 10(9): S448-S448.
Abstracts (Zeitschrift)
Normal tissue complication models for acute esophagitis in patients treated with accelerated radiotherapy
Zehentmayr, F; Söhn, M; Exeli, AK; Wurstbauer, K; Tröller, A; Fastner, G; Fussl, C; Belka, C; Studnicka, M; Sedlmayer, F;
Radiotherapy and Oncology. 2015; 115(Supplement 1):630-630.-ESTRO 2015; 24.-28.04.2015; Barcelona.
Abstracts (Zeitschrift)
2014
Beiträge in Fachzeitschriften
Hypofractionated stereotactic radiotherapy of acoustic neuroma : Volume changes and hearing results after 89-month median follow-up.
Kranzinger, M; Zehentmayr, F; Fastner, G; Oberascher, G; Merz, F; Nairz, O; Rahim, H; Sedlmayer, F;
Strahlenther Onkol. 2014; 190(9): 798-805.
Originalarbeiten (Zeitschrift)
Boost IORT in Breast Cancer: Body of Evidence.
Sedlmayer, F; Reitsamer, R; Fussl, C; Ziegler, I; Zehentmayr, F; Deutschmann, H; Kopp, P; Fastner, G;
Int J Breast Cancer. 2014; 2014: 472516
Übersichtsarbeiten
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
First Interim Analysis of the HIOB-Study: hypofractionated Whole-Breast-Irradiation with intraoperative Electron-Boost during breast-preserving Surgery for Breast Cancer: a prospective multicenter Study
Fastner, G; Reitsamer, R; Fussl, C; Kopp, P; Zehentmayr, F; Murawa, D; Karzcewska, A; Hager, E; Ciabattoni, A; Brimmer, R; Reiland, J; Sedlmayer, F
STRAHLENTHER ONKOL. 2014; 190(1): 118-118.
Abstracts (Zeitschrift)
DART - bid (dose-Differentiated Accelerated Radiation Therapy, 1.8 Gy twice daily): An Alternative for the locoregional advanced non-small Lung Cell Cancer (NSCLC)?
Wurstbauer, K; Deutschmann, H; Zehentmayr, F; Fussl, C; Dagn, K; Kopp, P; Porsch, P; Maurer, B; Blaukovitsch, M; Studnicka, M; Sedlmayer, F
STRAHLENTHER ONKOL. 2014; 190: 104-104.
Abstracts (Zeitschrift)
DART-BID (Differentiated Accelerated Radiation Therapy-1.8 Gy Twice Daily) for Locoregionally Advanced NSCLC: Mature Results of a Novel Therapeutic Approach
Wurstbauer, K; Deutschmann, H; Zehentmayr, F; Fussl, C; Dagn, K; Kopp, P; Porsch, P; Maurer, B; Blaukovitsch, M; Studnicka, M; Sedlmayr, F
INT J RADIAT ONCOL. 2014; 90: S625-S626.
Abstracts (Zeitschrift)
MicroRNAs as predictors of local control in breast cancer
Zehentmayr, F; Hauser-Kronberger, C; Fastner, G; Hlubek, F; Schuster, C; Luger, P; Reitsamer, R; Fischer, TH; Deutschmann, H; Sedlmayer, F;
Radiotherapy and Oncology. 2014; 111(Supplement 1):298-298.-ESTRO 2014; 04.-08.04.2014; Wien.
Abstracts (Zeitschrift)
MicroRNA (miR) patterns in breast cancer patients as a predictor of loco-regional control: an explorative pilot study
Zehentmayr, F; Hauser-Kronberger, C; Fastner, G; Reitsamer, R; Deutschmann, H; Fischer, T; Sedlmayer, F
STRAHLENTHER ONKOL. 2014; 190(1): 116-116.
Abstracts (Zeitschrift)
2013
Beiträge in Fachzeitschriften
Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer, F; Zehentmayr, F; Fastner, G
BREAST. 2013; 22 Suppl 2: S141-S146.
Originalarbeiten (Zeitschrift)
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)-a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume
Wurstbauer, K; Deutschmann, H; Dagn, K; Kopp, P; Zehentmayr, F; Lamprecht, B; Porsch, P; Wegleitner, B; Studnicka, M; Sedlmayer, F
RADIAT ONCOL. 2013; 8:
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
DART - BID (DOSE-DIFFERENTIATED ACCELERATED RADIATION THERAPY, 1.8 GY TWICE DAILY): A NOVEL THERAPEUTIC APPROACH FOR LOCOREGIONALLY ADVANCED, NONRESECTED NON-SMALL CELL LUNG CANCER
Deutschmann, H; Wurstbauer, K; Dagn, K; Zehentmayr, F; Kopp, P; Fussl, C; Porsch, P; Maurer, B; Blaukovitsch, M; Studnicka, M; Sedlmayer, F
J THORAC ONCOL. 2013; 8: S400-S401.
Abstracts (Zeitschrift)
Accelerated normofractionation in medically inoperable stage I non-small cell lung cancer yields excellent local control
Zehentmayr, F; Sedlmayer, F; Deutschmann, H; Dagn, K; Fussl, C; Kopp, P; Porsch, P; Wegleitner, B; Studnicka, M; Wurstbauer, K
EUR J CANCER. 2013; 49: S814-S814.
Abstracts (Zeitschrift)
2012
Beiträge in Fachzeitschriften
Prospective evaluation of quality of life effects in patients undergoing palliative radiotherapy for brain metastases.
Steinmann, D; Paelecke-Habermann, Y; Geinitz, H; Aschoff, R; Bayerl, A; Bölling, T; Bosch, E; Bruns, F; Eichenseder-Seiss, U; Gerstein, J; Gharbi, N; Hagg, J; Hipp, M; Kleff, I; Müller, A; Schäfer, C; Schleicher, U; Sehlen, S; Theodorou, M; Wypior, HJ; Zehentmayr, F; van Oorschot, B; Vordermark, D;
BMC Cancer. 2012; 12:283
Originalarbeiten (Zeitschrift)
[Radiotherapy of rectal cancer].
Wolf, M; Zehentmayr, F; Belka, C;
Radiologe. 2012; 52(6): 545-549.
Originalarbeiten (Zeitschrift)
Treatment strategies for oesophageal cancer - time-trends and long term outcome data from a large tertiary referral centre.
Wolf, MC; Zehentmayr, F; Schmidt, M; Hölzel, D; Belka, C;
Radiat Oncol. 2012; 7: 60
Originalarbeiten (Zeitschrift)
2011
Beiträge in Fachzeitschriften
MicroRNA expression profiles in human cancer cells after ionizing radiation.
Niemoeller, OM; Niyazi, M; Corradini, S; Zehentmayr, F; Li, M; Lauber, K; Belka, C;
Radiat Oncol. 2011; 6: 29
Originalarbeiten (Zeitschrift)
MiRNA expression patterns predict survival in glioblastoma.
Niyazi, M; Zehentmayr, F; Niemöller, OM; Eigenbrod, S; Kretzschmar, H; Schulze-Osthoff, K; Tonn, JC; Atkinson, M; Mörtl, S; Belka, C;
Radiat Oncol. 2011; 6: 153
Originalarbeiten (Zeitschrift)
Curative treatment of oesophageal carcinoma: current options and future developments.
Wolf, MC; Stahl, M; Krause, BJ; Bonavina, L; Bruns, C; Belka, C; Zehentmayr, F;
Radiat Oncol. 2011; 6: 55
Übersichtsarbeiten
[Neoadjuvant radiochemotherapy for rectal cancer].
Zehentmayr, F; Wolf, M; Weissenborn, Y; Feldmann, HJ; Belka, C;
MMW Fortschr Med. 2011; 153(35):31-33
Originalarbeiten (Zeitschrift)
2010
Beiträge in Fachzeitschriften
Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.
Wolf, M; Zehentmayr, F; Niyazi, M; Ganswindt, U; Haimerl, W; Schmidt, M; Hölzel, D; Belka, C;
Strahlenther Onkol. 2010; 186(7): 374-381.
Originalarbeiten (Zeitschrift)
2009
Beiträge in Fachzeitschriften
Job stress and job satisfaction of physicians, radiographers, nurses and physicists working in radiotherapy: a multicenter analysis by the DEGRO Quality of Life Work Group.
Sehlen, S; Vordermark, D; Schäfer, C; Herschbach, P; Bayerl, A; Pigorsch, S; Rittweger, J; Dormin, C; Bölling, T; Wypior, HJ; Zehentmayr, F; Schulze, W; Geinitz, H;
Radiat Oncol. 2009; 4:6
Originalarbeiten (Zeitschrift)
Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen
Neoadjuvant chemoradiation therapy with capecitabine (X) plus cetuximab (C), and external beam radiotherapy (RT) in locally advanced rectal cancer (LARC): ABCSG trial R03
Eisterer, WM; De Vries, A; Oefner, D; Greil, R; Rabl, H; Tschmelitsch, J; Schmid, R; Kapp, K; Zehentmayr, F; Thaler, J
J CLIN ONCOL. 2009; 27(15):
Abstracts (Zeitschrift)
2008
Beiträge in Fachzeitschriften
"Augmented reality" in conventional simulation by projection of 3-D structures into 2-D images: a comparison with virtual methods.
Deutschmann, H; Steininger, P; Nairz, O; Kopp, P; Merz, F; Wurstbauer, K; Zehentmayr, F; Fastner, G; Kranzinger, M; Kametriser, G; Kopp, M; Sedlmayer, F;
Strahlenther Onkol. 2008; 184(2):93-99
Originalarbeiten (Zeitschrift)
A strategy for the use of image-guided radiotherapy (IGRT) on linear accelerators and its impact on treatment margins for prostate cancer patients.
Nairz, O; Merz, F; Deutschmann, H; Kopp, P; Schöller, H; Zehentmayr, F; Wurstbauer, K; Kametriser, G; Sedlmayer, F;
Strahlenther Onkol. 2008; 184(12):663-667
Originalarbeiten (Zeitschrift)